SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-141351
Filing Date
2022-05-05
Accepted
2022-05-05 07:45:34
Documents
15
Period of Report
2022-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d349688d8k.htm   iXBRL 8-K 28857
2 EX-99.1 d349688dex991.htm EX-99.1 70692
7 GRAPHIC g349688g0505030851372.jpg GRAPHIC 4784
  Complete submission text file 0001193125-22-141351.txt   281963

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tmb-20220505.xsd EX-101.SCH 3934
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20220505_def.xml EX-101.DEF 14136
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20220505_lab.xml EX-101.LAB 23509
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20220505_pre.xml EX-101.PRE 15162
9 EXTRACTED XBRL INSTANCE DOCUMENT d349688d8k_htm.xml XML 6654
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 22894122
SIC: 2834 Pharmaceutical Preparations